Need help? Reach out to us
Back to library

Healthcare and pharma

Macleods Pharmaceuticals Regulatory Affairs Executive Interview: Rounds, Questions and Preparation

For Regulatory Affairs Executive roles at companies like Macleods Pharmaceuticals

Share with friends

Preparing together? Send them this role's questions.

https://www.cynchrony.in/library/macleods-pharmaceuticals-regulatory-affairs-executive

What the job involves

Regulatory Affairs Executives in pharma ensure that a company's drug products comply with CDSCO, FDA, and other regulatory requirements before and after approval. Day to day, they compile and review dossiers, track submissions, respond to queries from authorities, and keep product labels and documentation current. At an established Indian manufacturer like Macleods Pharmaceuticals, the role often involves preparing ANDA, NDDS, or export registration documents and coordinating with R&D, QA, and manufacturing teams.

Role and Technical Knowledge

  1. 1

    What is the difference between CTD and eCTD, and why is eCTD preferred today?

    Explain that CTD is a paper or PDF format with five modules, while eCTD is an electronic XML-based version that allows lifecycle tracking and faster review. Mention that eCTD is now mandatory for many regulated markets.

  2. 2

    Explain the five modules of a Common Technical Document (CTD).

    Cover Module 1 (regional administrative), Module 2 (quality, nonclinical, clinical overviews), Module 3 (quality), Module 4 (nonclinical study reports), and Module 5 (clinical study reports). Highlight that Module 1 varies by country.

  3. 3

    What are the key requirements of Schedule M under the Drugs and Cosmetics Act?

    Focus on good manufacturing practices for premises, plant, equipment, personnel, and documentation. Mention that Schedule M was revised to align with WHO-GMP and that regulatory affairs must ensure site records match dossier claims.

  4. 4

    What is the role of ICH Q1A(R2) in stability testing?

    State that it provides the stability testing protocol for new drug substances and products, including storage conditions, testing frequency, and shelf-life justification. Explain how stability data supports the shelf life in the dossier.

Practical Scenarios

  1. 5

    You are preparing an ANDA for a generic tablet. What documents would you gather first, and why?

    Start with the drug master file, certificate of analysis, stability data, manufacturing process, and labeling. Explain that these form the core of Modules 2 and 3 and must be consistent with the reference listed drug.

  2. 6

    A regulatory authority sends a query about a discrepancy in your stability data. How do you handle it?

    Describe verifying the data with the lab, checking for transcription errors, and preparing a clear response with supporting raw data. Mention that you would document the query and response in the regulatory tracker.

  3. 7

    You notice that a product label submitted to CDSCO has an incorrect excipient name. What steps do you take?

    Explain that you would immediately inform your supervisor, check the approved dossier version, and file a correction or amendment before approval. Emphasize not hiding the error and following SOPs.

  4. 8

    How would you prioritize your work if you have three submissions due in the same week and one is for an export market?

    Talk about assessing regulatory deadlines, market importance, and dependencies. Suggest communicating with the team, using a checklist, and escalating if timelines conflict.

Behavioural and Situational Questions

  1. 9

    Tell me about a time you had to pay close attention to detail under pressure.

    Use a STAR example from college projects or internships where a small error was caught. Highlight your method for double-checking and the outcome.

  2. 10

    How do you handle feedback when a senior points out a mistake in your documentation?

    Show that you accept feedback professionally, ask clarifying questions, correct the error, and update your personal checklist to avoid repetition.

  3. 11

    Describe a situation where you had to explain a complex rule or process to someone who did not have a technical background.

    Pick an example from a group project or presentation. Focus on simplifying without losing accuracy and confirming understanding.

  4. 12

    Why do you want to work in regulatory affairs rather than in research or production?

    Connect your interest in rules, documentation, and patient safety to the role. Mention that regulatory affairs lets you see the full product lifecycle and ensures compliance.

HR and Company Fit

  1. 13

    What do you know about Macleods Pharmaceuticals and its product portfolio?

    Research the company's presence in generics, anti-infectives, and exports. Mention a few therapeutic areas and its regulatory footprint in India and abroad without claiming insider knowledge.

  2. 14

    How do you keep yourself updated on changes in Indian pharmaceutical regulations?

    Name sources like CDSCO website, gazette notifications, and industry newsletters. Mention following regulatory updates and discussing them with seniors or peers.

  3. 15

    Where do you see yourself in three years in regulatory affairs?

    Show a learning path: from executive to senior executive, gaining expertise in eCTD and global submissions. Emphasize contributing to faster approvals and compliance.

  4. 16

    Are you comfortable working with strict deadlines and repetitive documentation tasks?

    Answer yes and give an example of maintaining accuracy in repetitive work, such as lab records or college assignments. Highlight your patience and organizational skills.

Ready to try it for real?

Take a timed test or talk through a mock interview for this role, then see your scores.

This is practice material for Regulatory Affairs Executive roles, written with AI. It is not a list of questions Macleods Pharmaceuticals or any other company has asked.